Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2024-03-12 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and references compliance with German Securities Trading Act (WpHG) sections (Article 40, Section 1, Section 33, 34, and 43). It details notifications regarding the acquisition and objectives of voting rights held by UBS Group AG in MorphoSys AG. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels or voting rights, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category (DVA), although the content is more about the holding notification than the final results of a vote. However, given the specific nature of 'Voting Rights Announcements' in the header, DVA is the most precise fit among the provided options, as it covers voting rights notifications.
2024-03-12 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains sections detailing the 'Notification of Major Holdings' as per German securities law (WpHG). It reports changes in the percentage of voting rights held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG, including details on shares and instruments. This directly corresponds to the definition of a notification regarding changes in significant share ownership levels, which aligns best with the 'Major Shareholding Notification' category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, MRQ is the specific regulatory filing type for reporting these changes in holdings thresholds.
2024-03-11 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled 'Voting Rights Announcements' and explicitly states 'Notification of Major Holdings' under German Securities Trading Act (WpHG). It details changes in voting rights percentages held by a legal entity (Société Générale S.A.) in MorphoSys AG, crossing or reaching specific thresholds. This directly corresponds to the definition of reporting changes in significant share ownership levels. Reviewing the definitions: - 10-K/IR: Not a full annual or interim financial report. - ER: Not an earnings release. - DIRS: This is about director's personal trades, whereas this is about a major institutional shareholder's holding change. - MRQ (Major Shareholding Notification): This category perfectly matches the content, which is a notification of a change in major shareholding (voting rights announcement). Therefore, the classification is MRQ.
2024-03-11 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights attached to shares, and instruments (like options/warrants) that affect voting rights, referencing specific sections of the German Securities Trading Act (WpHG). This structure perfectly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the content is a formal disclosure of holding percentages by a major shareholder (The Goldman Sachs Group, Inc.), making MRQ the most precise fit over DVA (which is for voting results) or DIRS (which is for director's personal trades).
2024-03-08 English
Declaration of Voting Results & Voting Rights Announcements 2024
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, specifically focusing on 'Notification of Major Holdings' under German Securities Trading Act (WpHG) regulations. Section 6 details the 'Total positions' of voting rights, and Section 5 specifies the date the threshold was crossed. This content directly aligns with the definition of reporting changes in significant share ownership, which corresponds to the Major Shareholding Notification category (MRQ). Although the header mentions 'Voting Rights Announcements', the content structure is a formal notification of a major holding change by an entity (Société Générale S.A.).
2024-03-08 English
Invitation to MorphoSys Full Year Results 2023 Conference Call on March 14, 2024
Report Publication Announcement Classification · 1% confidence The document is an announcement titled "Invitation to MorphoSys’ Full Year Results 2023 Conference Call on March 14, 2024." It explicitly states that the company will publish its Full Year Results 2023 on March 13, 2024, and then invites participants to a conference call/webcast on March 14, 2024, to present these results. This structure—announcing the release of a report (Full Year Results 2023) and immediately inviting stakeholders to a call to discuss it—is characteristic of an Earnings Release (ER) or a precursor/announcement thereof. Since the document focuses on inviting people to the call where the results will be presented and discussed (including Q&A), it strongly aligns with the purpose of an Earnings Release (ER) or a Call Transcript (CT) announcement. Given the focus is on the *invitation* to the call where the results are presented, and it mentions the upcoming publication of the 'results for the financial year 2023', it is best classified as an Earnings Release (ER) announcement, which typically precedes or coincides with the release of the detailed results and the associated call. It is not the full transcript (CT) yet, nor is it the comprehensive 10-K. It is the announcement of the earnings event.
2024-03-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.